Autologous Cord Blood Cells Infusion as Salvage Therapy for Engraftment Failure After Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Autologous Cord Blood Cells Infusion as Salvage Therapy for Engraftment Failure After Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Published:2016-03-22 Issue:8 Volume:63 Page:1495-1496
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

de Rojas Teresa¹,Fioravantti Victoria¹,Deltoro Natalia¹,Andión Maitane¹,González-Vicent Marta¹,Madero Luis¹

Affiliation:

1. Pediatric Oncology, Hematology and Stem Cell Transplant Department; Hospital Infantil Universitario Niño Jesús; Madrid Spain

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25974/fullpdf

Reference10 articles.

1. Cord blood banking and transplantation: Advances and controversies;Yoder;Curr Opin Pediatr,2014;

2. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: Update of the 2005 evidence-based review;Oliansy;ASBMT Position Statement. Biol Blood Marrow Transplant,2012

3. Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the AEIOP AML-2002/01 study;Locatelli;Bone Marrow Transplant,2015

4. Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation;Locatelli;Expert Opin Pharmacother,2014

5. Sociedad Española de Hematología y Oncología Pediátricas. Protocolo SHOP LMA 2007 http://www.recerca.com/shop/entrar/prot_pdf/LMA2007_PROTOCOLO.pdf

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies;Biology of Blood and Marrow Transplantation;2019-07